[go: up one dir, main page]

NO20005671D0 - Metabolitter av ecteinascidin 743 - Google Patents

Metabolitter av ecteinascidin 743

Info

Publication number
NO20005671D0
NO20005671D0 NO20005671A NO20005671A NO20005671D0 NO 20005671 D0 NO20005671 D0 NO 20005671D0 NO 20005671 A NO20005671 A NO 20005671A NO 20005671 A NO20005671 A NO 20005671A NO 20005671 D0 NO20005671 D0 NO 20005671D0
Authority
NO
Norway
Prior art keywords
etm
ecteinascidin
metabolites
compounds
abbreviated
Prior art date
Application number
NO20005671A
Other languages
English (en)
Other versions
NO20005671L (no
NO318081B1 (no
Inventor
Kenneth Lloyd Rinehart
Jose J Morales
Joel Reid
Isabel Reymundo
Pablo Floriano
Lola Garcia Gravalos
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20005671D0 publication Critical patent/NO20005671D0/no
Publication of NO20005671L publication Critical patent/NO20005671L/no
Publication of NO318081B1 publication Critical patent/NO318081B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/10—Quaternary compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20005671A 1998-05-11 2000-11-10 Metabolitter av ecteinascidin 743, farmasoytiske preparater inneholdende dem, samt metode for bestemmelse av matabolitter derav NO318081B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8502498P 1998-05-11 1998-05-11
PCT/US1999/010233 WO1999058125A1 (en) 1998-05-11 1999-05-11 Metabolites of ecteinascidin 743

Publications (3)

Publication Number Publication Date
NO20005671D0 true NO20005671D0 (no) 2000-11-10
NO20005671L NO20005671L (no) 2001-01-10
NO318081B1 NO318081B1 (no) 2005-01-31

Family

ID=22188976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005671A NO318081B1 (no) 1998-05-11 2000-11-10 Metabolitter av ecteinascidin 743, farmasoytiske preparater inneholdende dem, samt metode for bestemmelse av matabolitter derav

Country Status (22)

Country Link
US (3) US6316214B1 (no)
EP (1) EP1077698B1 (no)
JP (2) JP4583598B2 (no)
KR (1) KR100643092B1 (no)
CN (3) CN1195514C (no)
AT (1) ATE289810T1 (no)
AU (1) AU759281B2 (no)
BG (1) BG65235B1 (no)
BR (1) BR9910419A (no)
CA (1) CA2331593C (no)
CZ (1) CZ302168B6 (no)
DE (1) DE69923965T2 (no)
ES (1) ES2239442T3 (no)
HU (1) HUP0101960A3 (no)
IL (2) IL139607A0 (no)
NO (1) NO318081B1 (no)
NZ (1) NZ508585A (no)
PL (1) PL192409B1 (no)
RU (1) RU2225864C2 (no)
SK (1) SK285069B6 (no)
TR (1) TR200003470T2 (no)
WO (1) WO1999058125A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100643092B1 (ko) 1998-05-11 2006-11-10 파르마 마르, 에스.에이. 엑테인아시딘 743의 대사산물
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
RU2266734C2 (ru) * 1999-05-13 2005-12-27 Фарма Мар, С.А. Композиции и применение ет743 для лечения злокачественных опухолей
AR035842A1 (es) * 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
US7919493B2 (en) 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02010088A (es) 2000-04-12 2004-08-19 Pharma Mar Sa Derivados de ecteinascidina antitumorales.
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) * 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
WO2002040477A2 (en) * 2000-11-03 2002-05-23 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
BR0115162A (pt) * 2000-11-06 2003-10-21 Pharma Mar Sa Tratamentos antitumorais eficazes
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
US7407327B2 (en) * 2003-03-21 2008-08-05 Seagate Technology Llc Method and system for withstanding shock in a spindle motor bearing
PT1689404E (pt) 2003-11-13 2008-12-15 Pharma Mar Sau Combinação de et-743 com pró-fármacos de fluorouracil para o tratamento do cancro
DK1658848T3 (da) 2004-10-29 2007-11-26 Pharma Mar Sa Formuleringer omfattende ecteinascidin og et disaccharid
RU2270536C9 (ru) * 2004-12-01 2006-06-10 Ооо "Твинн" Свч плазмохимический реактор
US20090325971A1 (en) * 2005-03-02 2009-12-31 The Trustees Of Columbia University In The City Of New York Pentacyclic Alkaloid Compounds and Methods of Use Thereof
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
US20090012157A1 (en) 2006-02-06 2009-01-08 Sears Barry D Sesamol Derivatives as Novel Inhibitors of Arachidonic Acid Formation
SI2786753T1 (sl) 2010-11-12 2019-05-31 Pharma Mar S.A. Kombinacijska terapija s protitumorskim antibiotikom
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
PH12022551216A1 (en) 2019-11-21 2023-07-17 Pharma Mar Sa Methods of treating small cell lung cancer with lurbinectedin formulations

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273773A (en) * 1979-09-24 1981-06-16 American Home Products Corporation Antihypertensive tricyclic isoindole derivatives
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
JPS6084288A (ja) 1983-10-13 1985-05-13 Shionogi & Co Ltd シアノキノナミンアセテ−ト類およびその製造法
US5089273A (en) 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
DE3774435D1 (de) 1986-06-09 1991-12-12 Univ Pennsylvania Ekteinascidine 729, 743, 745, 759a, 759b and 770.
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
TW221441B (no) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
ES2108165T3 (es) 1992-06-19 1997-12-16 Hoechst Ag Compuestos policiclicos 31668p y 31668u, un procedimiento para su produccion y su uso como agentes antibioticos o antitumorales.
US5426108A (en) * 1993-11-10 1995-06-20 American Cyanamid Company Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US5809563A (en) * 1996-11-12 1998-09-15 Institute For The Development Of Emerging Architectures, Llc Method and apparatus utilizing a region based page table walk bit
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
EP1876180A3 (en) * 1998-04-06 2009-12-16 The Board Of Trustees Of The University Of Illinois Semi-synthetic ecteinascidins
KR100643092B1 (ko) * 1998-05-11 2006-11-10 파르마 마르, 에스.에이. 엑테인아시딘 743의 대사산물
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
AR035842A1 (es) 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
JP2003520801A (ja) * 2000-01-19 2003-07-08 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク サフラマイシン−エクテイナシジン系列の化合物、それらの使用及び合成
MXPA02010088A (es) 2000-04-12 2004-08-19 Pharma Mar Sa Derivados de ecteinascidina antitumorales.
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.

Also Published As

Publication number Publication date
ATE289810T1 (de) 2005-03-15
RU2225864C2 (ru) 2004-03-20
CZ302168B6 (cs) 2010-11-24
AU759281B2 (en) 2003-04-10
KR100643092B1 (ko) 2006-11-10
IL139607A0 (en) 2002-02-10
JP2002514597A (ja) 2002-05-21
CA2331593C (en) 2008-08-05
US6316214B1 (en) 2001-11-13
SK17152000A3 (sk) 2001-07-10
NO20005671L (no) 2001-01-10
BG65235B1 (bg) 2007-09-28
CA2331593A1 (en) 1999-11-18
CN100339375C (zh) 2007-09-26
US6867334B2 (en) 2005-03-15
EP1077698A4 (en) 2002-05-08
PL344183A1 (en) 2001-10-08
CN1195514C (zh) 2005-04-06
ES2239442T3 (es) 2005-09-16
HUP0101960A2 (hu) 2001-11-28
PL192409B1 (pl) 2006-10-31
IL139607A (en) 2006-12-10
EP1077698A1 (en) 2001-02-28
CN1896064A (zh) 2007-01-17
TR200003470T2 (tr) 2001-06-21
DE69923965T2 (de) 2006-04-06
JP4583598B2 (ja) 2010-11-17
EP1077698B1 (en) 2005-03-02
JP2010215656A (ja) 2010-09-30
NZ508585A (en) 2002-11-26
BR9910419A (pt) 2001-01-09
NO318081B1 (no) 2005-01-31
DE69923965D1 (de) 2005-04-07
KR20010071237A (ko) 2001-07-28
CN100548988C (zh) 2009-10-14
AU4073799A (en) 1999-11-29
WO1999058125A1 (en) 1999-11-18
US20020032326A1 (en) 2002-03-14
BG105023A (en) 2001-08-31
US20050261326A1 (en) 2005-11-24
SK285069B6 (sk) 2006-05-04
CZ20004183A3 (en) 2001-06-13
CN1371279A (zh) 2002-09-25
US7115743B2 (en) 2006-10-03
CN1683299A (zh) 2005-10-19
HUP0101960A3 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
NO20005671D0 (no) Metabolitter av ecteinascidin 743
CL2004001072A1 (es) Compuestos derivados de trifluorofenil-triazolopirimidina; procedimiento de preparacion de los compuestos; compuestos intermediarios utiles como fungicidas.
WO2003106456A3 (en) Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
BR9808998A (pt) Imidazóis substituìdos úteis no tratamento de doenças inflamatórias
ATE205466T1 (de) Benzoyl derivate und ihre herstellung
BR9909488A (pt) Ecteinascidinas semi-sintéticas
DK0397336T3 (da) Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2
EP0914130A4 (en) NEW ANTIVIRAL COMPOSITIONS
DE60044369D1 (de) Synthetisches oligomannosid, seine herstellung und verwendung
ATE201195T1 (de) Tricyclische verbindungen
YU40798A (en) Benzopyran derivatives having leukotriene-antagonistic action
SE9901077D0 (sv) Novel use
UA27022C2 (uk) Похідhі карбазолоhу як проміжhі сполуки для отримаhhя оhдаhсетроhу
YU37597A (en) New pyranosid derivatives
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
ATE196292T1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
PL318351A1 (en) Benzoyl derivatives and their synthesis
ATE176242T1 (de) Uck14-verbindungen
DE69706441D1 (de) Tetracyclische aromatische retinoide verbindungen, ihre herstellung und verwendung
NO20014937D0 (no) Naturlige pseudomycinprodukter
DE60222236D1 (de) Zubereitungen enthaltend cyclohexamantan
IT1317000B1 (it) Uso di composti di origine naturale ad attivita' antiangiogenica.
DE69816095D1 (de) Herstellung von beta-mehtylcarbapenem-zwischenprodukten

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees